表 1.
TBSR组和RABSR组治疗策略
Treatment strategies of TBSR group and RABSR group
| Treatment strategies | TBSR group (n=7) | RABSR group (n=6) |
| TBSR: thoracotomy bronchial sleeve resection; RABSR: robot-assisted bronchial sleeve resection; PD-1: programmed death protein-1 | ||
| Chemoimmunotherapy | ||
| Paclitaxel+cisplatin (carboplatin) | 7 | 6 |
| Anti-PD-1 | ||
| Pembrolizumab | 2 | 1 |
| Sintilimab | 1 | 2 |
| Camrelizumab | 4 | 3 |
| Middle neoadjuvant therapy cycles | 3 (2-4) | 3 (2-4) |
| Interval between neoadjuvant therapy and surgery (d) | 36 (30-54) | 34 (28-48) |